---
title: "RPC PHARMA LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0fce285e-7ebb-5497-bb22-c6c7fb77cbf0
json: https://whiteintel.dev/api/public/dossier/0fce285e-7ebb-5497-bb22-c6c7fb77cbf0
identifier: sec:0001653315
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# RPC PHARMA LTD

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001653315`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0fce285e-7ebb-5497-bb22-c6c7fb77cbf0  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0fce285e-7ebb-5497-bb22-c6c7fb77cbf0  

## Ownership & control

### Holdings / subsidiaries

- **Akari Therapeutics Plc** (tenpercentowner) — https://whiteintel.dev/entity/2b19d013-cda4-53fc-825b-58822ac0d1a8

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **RPC PHARMA LTD**. Human view: https://whiteintel.dev/entity/0fce285e-7ebb-5497-bb22-c6c7fb77cbf0 · Structured JSON: https://whiteintel.dev/api/public/dossier/0fce285e-7ebb-5497-bb22-c6c7fb77cbf0._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._